38
Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’

Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

Pathology of endocrine pancreas

By: Shifaa’ Alqa’qa’

Page 2: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• major cell types:

Beta ----- insulin

Alpha ----- glucagon

Delta ----- somatostatin

PP (pancreatic polypeptide) cells ------ VIP

Page 3: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

DIABETES MELLITUS

• Normal blood glucose levels ????

• DM diagnosis:

1. A random blood glucose concentration of 200 mg/dL or higher, with classical signs and symptoms

2. A fasting glucose concentration of 126 mg/dL or higher on more than one occasion 3. An abnormal oral glucose tolerance test (OGTT), in which the glucose concentration is 200 mg/dL or higher 2 hours after a standard carbohydrate load (75 g of glucose).

Page 4: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• HbA1C ?????????

Page 5: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Prediabetes :

- impaired glucose tolerance

- serum fasting glucose greater than 110 but less than 126 mg/dL

- OGTT values of greater than 140 but less than

200 mg/dL

Risk for DM and cardiovascular disease

Page 6: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Classification:

- Type 1 diabetes (T1D) ---- 10%

- Type 2 diabetes (T2D) ---- 80% to 90%

- monogenic and secondary causes

Page 7: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----
Page 8: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----
Page 9: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----
Page 10: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----
Page 11: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

PATHOGENESIS

• Type 1 Diabetes Mellitus:

- autoimmune disease ------ failure of self tolerance in T cells, autoantibodies

- Childhood------ puberty------ more than 90% of the beta cells have been destroyed

- Insulitis ----- early

Page 12: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• genetic susceptibility ----

HLA-DR3, or DR4 class II MHC (ch6)

CTLA4 and PTPN22 genes (excessive T cell activation)

• environmental factors---------

Infections ----- viruses (mumps, rubella, and coxsackie B (molecular mimicry)

Page 13: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Type 2 Diabetes Mellitus: complex multifactorial disease - Genetic factors: Diabetogenic genes - Environmental factors: sedentary life style, dietary habits insulin resistance --------------- beta cell hyperfunction and hyperinsulinemia in the early stages ---------------- beta cell dysfunction

Page 14: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----
Page 15: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Insulin Resistance:

failure of target tissues to respond normally to insulin

- decreased uptake of glucose in muscle,

- reduced glycolysis and fatty acid oxidation in the liver,

- an inability to suppress hepatic gluconeogenesis

Page 16: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Obesity and Insulin Resistance:

metabolic syndrome ---- DM 2

- excess free fatty acids (FFAs)----Intracellular triglycerides (muscle, liver)

- FFA ----- Inflammation ---- inflammasome -------proinflammatory cytokines ---- IL-1β ---- macrophages and other cells, adipokines (fat cells)

Page 17: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Beta Cell Dysfunction:

- FFAs

- pro-inflammatory cytokines from beta cells

- recruitment of mononuclear cells (macrophages and T cells) into the islets

- cytokine production

- Amyloid replacement of islets ---- islet amyloid polypetide (IAPP)

Page 18: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

Monogenic Forms of Diabetes

• monogenic forms of diabetes are uncommon examples of the diabetic phenotype occurring as a result of loss-of-function mutations within a single gene.

• maturity-onset diabetes of the young (MODY)

Page 19: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----
Page 20: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

Complications of Diabetes

• The pathogenesis of the long-term complications of diabetes: 1. Formation of advanced glycation end products (AGEs): AGEs ---hyperglycemia---- glucose-derived precursors- amino groups of proteins. AGE-RAGE (receptor of AGE on inflammatory cells,endothelium, vascular smooth muscle )---- pro-inflammatory cytokines---- reactive oxygen species---- procoagulant activity-- proliferation of vascular smooth muscle cells and synthesis of extracellular matrix AGEs can directly cross-link extracellular matrix proteins---- enhancing protein deposition-----trap other plasma or interstitial proteins---- (LDL) accelerating atherosclerosis---------- (albumin) basement membrane thickening

Page 21: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Activation of protein kinase C:

Intracellular hyperglycemia-----stimulate the de novo synthesis of DAG (diacylglycerol) ----activation of PKC---- production of proangiogenic

molecules (VEGF) ----- neovascularization

Page 22: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Disturbances in polyol pathways:

Hyperglycemia----- increase in intracellular glucose (nerves, lens, kidneys, blood vessels)----- aldose reductase----- sorbitol (polyol) ----- NADPH ------ fructose ---- reduction in GSH (antioxidant) ----- oxidative stress ----- diabetic neuropathy

Page 23: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• complications appear approximately 15 to 20 years after the onset of hyperglycemia

Page 24: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• macrovascular disease

• Basement membranes of small vessels (microangiopathy),

• Kidneys (diabetic nephropathy),

• retina (retinopathy),

• Nerves (neuropathy)

Page 25: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Pancreas:

- Reduction in the number and size of islets

- Leukocytic infiltration of the islets---- More in Type1

- Amyloid replacement of islets in long-standing

type 2 diabetes

- An increase in the number and size of islets ????

Page 26: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Diabetic Macrovascular Disease:

accelerated atherosclerosis

Myocardial infarction

Gangrene of the lower extremities

Hyaline arteriolosclerosis ????

Page 27: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Diabetic Microangiopathy:

diffuse thickening of basement membranes

leaky

Diabetic nephropathy,

Retinopathy

neuropathy

Page 28: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Diabetic Nephropathy:

(1) glomerular lesions (thick BM)----

Diffuse mesangial sclerosis---- Nodular glomerulosclerosis ----- nephrotic syndrome

(2) renal vascular lesions ---- Renal atherosclerosis and arteriolosclerosis---- macrovascular disease

(3) pyelonephritis, including necrotizing papillitis

(4) end-stage renal disease

Page 29: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Ocular Complications of Diabetes:

- Nonproliferative retinopathy (microangiopathy: hemorrhages, retinal exudates, microaneurysms, venous dilations, edema)

- proliferative retinopathy (neovascularization--- Vitreous hemorrhages---organization----retinal detachment----blindness )

- Cataract formation,

- glaucoma

Page 30: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Diabetic Neuropathy (microangiopathy) :

- peripheral, symmetric neuropathy of the lower extremities affecting both motor and sensory function

- autonomic neuropathy

- diabetic mononeuropathy (footdrop or wristdrop)

Page 31: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

Clinical Features:

type 1 diabetes:

honeymoon period????

Infection ---- abrupt ----- polyuria (glycosuria) , polydipsia, polyphagia, and in severe cases, ketoacidosis (500 to 700 mg/dL, dehydration, lipase--- FFAs---oxidized by the liver to produce ketones---- metabolic acidosis ---- nausea, vomiting, respiratory difficulties

weight loss and muscle weakness

Page 32: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Type 2 diabetes mellitus:

older than 40 years and frequently are obese

osmotic diuresis---- dehydration---- hyperosmolar nonketotic coma-----delays recognition of the seriousness of the situation until the onset of severe dehydration and coma.

Page 33: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Diabetic patients are plagued by an enhanced susceptibility to infections of the skin, as well as to tuberculosis, pneumonia, and pyelonephritis

Page 34: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----
Page 35: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----
Page 36: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

PANCREATIC NEUROENDOCRINE TUMORS

• islet cell tumors

• Nonfunctional,

• Functional

• malignant

• benign

Page 37: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Insulinomas----

Mc

attacks of hypoglycemia, below 50 mg/dL ( central nervous system manifestations as confusion, stupor, and loss of consciousness). They are precipitated by fasting or exercise and are promptly relieved by feeding or parenteral administration of glucose

Page 38: Pathology of endocrine pancreas...Pathology of endocrine pancreas By: Shifaa’ Alqa’qa’ ... •islet cell tumors •Nonfunctional, •Functional • malignant •benign •Insulinomas----

• Gastrinomas:

Zollinger-Ellison syndrome????

peptic ulceration

diarrhea